221 related articles for article (PubMed ID: 26774950)
1. Development of a Model for Chemotherapy-Induced Alopecia: Profiling of Histological Changes in Human Hair Follicles after Chemotherapy.
Yoon JS; Choi M; Shin CY; Paik SH; Kim KH; Kwon O
J Invest Dermatol; 2016 Mar; 136(3):584-92. PubMed ID: 26774950
[TBL] [Abstract][Full Text] [Related]
2. A guide to assessing damage response pathways of the hair follicle: lessons from cyclophosphamide-induced alopecia in mice.
Hendrix S; Handjiski B; Peters EM; Paus R
J Invest Dermatol; 2005 Jul; 125(1):42-51. PubMed ID: 15982301
[TBL] [Abstract][Full Text] [Related]
3. A new strategy for modulating chemotherapy-induced alopecia, using PTH/PTHrP receptor agonist and antagonist.
Peters EM; Foitzik K; Paus R; Ray S; Holick MF
J Invest Dermatol; 2001 Aug; 117(2):173-8. PubMed ID: 11511291
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment of epidermal growth factor promotes primary hair recovery via the dystrophic anagen pathway after chemotherapy-induced alopecia.
Paik SH; Yoon JS; Ryu HH; Lee JY; Shin CY; Min KH; Jo SJ; Kim KH; Kwon O
Exp Dermatol; 2013 Jul; 22(7):496-9. PubMed ID: 23800066
[TBL] [Abstract][Full Text] [Related]
5. Human placenta induces hair regrowth in chemotherapy-induced alopecia via inhibition of apoptotic factors and proliferation of hair follicles.
Kim MH; Kim K; Lee H; Yang WM
BMC Complement Med Ther; 2020 Jul; 20(1):230. PubMed ID: 32689985
[TBL] [Abstract][Full Text] [Related]
6. Dissecting the impact of chemotherapy on the human hair follicle: a pragmatic in vitro assay for studying the pathogenesis and potential management of hair follicle dystrophy.
Bodó E; Tobin DJ; Kamenisch Y; Bíró T; Berneburg M; Funk W; Paus R
Am J Pathol; 2007 Oct; 171(4):1153-67. PubMed ID: 17823286
[TBL] [Abstract][Full Text] [Related]
7. Splenic melanosis during normal murine C57BL/6 hair cycle and after chemotherapy.
Michalczyk-Wetula D; Salwiński A; Popik M; Jakubowska M; Płonka PM
Acta Biochim Pol; 2013; 60(3):313-21. PubMed ID: 23828776
[TBL] [Abstract][Full Text] [Related]
8. Preventive effects of cedrol against alopecia in cyclophosphamide-treated mice.
Chen SS; Zhang Y; Lu QL; Lin Z; Zhao Y
Environ Toxicol Pharmacol; 2016 Sep; 46():270-276. PubMed ID: 27522546
[TBL] [Abstract][Full Text] [Related]
9. Fas and c-kit are involved in the control of hair follicle melanocyte apoptosis and migration in chemotherapy-induced hair loss.
Sharov AA; Li GZ; Palkina TN; Sharova TY; Gilchrest BA; Botchkarev VA
J Invest Dermatol; 2003 Jan; 120(1):27-35. PubMed ID: 12535195
[TBL] [Abstract][Full Text] [Related]
10. Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia.
Maurer M; Handjiski B; Paus R
Am J Pathol; 1997 Apr; 150(4):1433-41. PubMed ID: 9094998
[TBL] [Abstract][Full Text] [Related]
11. Do hair bulb melanocytes undergo apoptosis during hair follicle regression (catagen)?
Tobin DJ; Hagen E; Botchkarev VA; Paus R
J Invest Dermatol; 1998 Dec; 111(6):941-7. PubMed ID: 9856800
[TBL] [Abstract][Full Text] [Related]
12. Pathobiology of chemotherapy-induced hair loss.
Paus R; Haslam IS; Sharov AA; Botchkarev VA
Lancet Oncol; 2013 Feb; 14(2):e50-9. PubMed ID: 23369683
[TBL] [Abstract][Full Text] [Related]
13. Treatment and prevention of chemotherapy-induced alopecia with PTH-CBD, a collagen-targeted parathyroid hormone analog, in a non-depilated mouse model.
Katikaneni R; Ponnapakkam T; Matsushita O; Sakon J; Gensure R
Anticancer Drugs; 2014 Jan; 25(1):30-8. PubMed ID: 24025564
[TBL] [Abstract][Full Text] [Related]
14. Topical estrogen accelerates hair regrowth in mice after chemotherapy-induced alopecia by favoring the dystrophic catagen response pathway to damage.
Ohnemus U; Unalan M; Handjiski B; Paus R
J Invest Dermatol; 2004 Jan; 122(1):7-13. PubMed ID: 14962083
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone.
Paus R; Handjiski B; Eichmüller S; Czarnetzki BM
Am J Pathol; 1994 Apr; 144(4):719-34. PubMed ID: 8160773
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 is expressed on multipotent cells of hair follicles and might be involved in their resistance to chemotherapy.
Selleri S; Arnaboldi F; Palazzo M; Hussein U; Balsari A; Rumio C
Br J Dermatol; 2005 Sep; 153(3):506-13. PubMed ID: 16120134
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Bcl-2 protects from ultraviolet B-induced apoptosis but promotes hair follicle regression and chemotherapy-induced alopecia.
Müller-Röver S; Rossiter H; Paus R; Handjiski B; Peters EM; Murphy JE; Mecklenburg L; Kupper TS
Am J Pathol; 2000 Apr; 156(4):1395-405. PubMed ID: 10751363
[TBL] [Abstract][Full Text] [Related]
18. Topical application of cyclosporin A induces rapid-remodeling of damaged anagen hair follicles produced in cyclophosphamide administered mice.
Shirai A; Tsunoda H; Tamaoki T; Kamiya T
J Dermatol Sci; 2001 Sep; 27(1):7-13. PubMed ID: 11457638
[TBL] [Abstract][Full Text] [Related]
19. Effect of adenovirus-mediated expression of Sonic hedgehog gene on hair regrowth in mice with chemotherapy-induced alopecia.
Sato N; Leopold PL; Crystal RG
J Natl Cancer Inst; 2001 Dec; 93(24):1858-64. PubMed ID: 11752010
[TBL] [Abstract][Full Text] [Related]
20. p53 is essential for chemotherapy-induced hair loss.
Botchkarev VA; Komarova EA; Siebenhaar F; Botchkareva NV; Komarov PG; Maurer M; Gilchrest BA; Gudkov AV
Cancer Res; 2000 Sep; 60(18):5002-6. PubMed ID: 11016618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
